TCL Archive Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says November 28, 2014
TCL Archive Centers Network Release “Version 1.0” Of Clinical Guidelines for Eight Cancers March 15, 1996
TCL Archive FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC. March 30, 2001
